Catalyst Wire Dossier Catalyst Wire Dossier

fluticasone/formoterol K-haler (Medium Strength)

fluticasone/formoterol · Mundipharma Pharmaceuticals S.L.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for fluticasone/formoterol K-haler (Medium Strength), covering 2020-07-07 to 2020-07-07. Get the full timeline:

Most recent: Clinical Trial Update: Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients [Phase 4]

See pricing